Our business
Our Products
Cardiac catheterization products
We have the largest market share in the products for percutaneous coronary intervention(PCI), minimally invasive medical care for myocardial infarction and angina pectoris in Japan.
*(Source) WIN Partners
Sales breakdown for FY2024
Our specialty is in minimally invasive medical care particularly in the heart treatment field, including PCI, CRS and CVS, and approximately 64% of our group’s sales account for heart treatment related products.
Expanding business fields to non-cardiac areas
The minimally invasive medical care field is now expanding from the heart to other areas, including the legs, brain, and neck, and accordingly, we are expanding our range of products from heart-related products to peripheral vascular disease-related (PPI), neurosurgery, and diabetes-related fields.
Product line-up
Percutaneous Coronary Intervention (PCI)
-
PTCA Balloon Catheter
-
Drug-Eluting Stent (DES)
-
Intravascular Ultrasound (IVUS) Catheter
Cardiac Rhythm Segment (CRS)
-
Pacemaker
-
Implantable Cardioverter Defibrillator (ICD)
-
Cardiac Resynchronization Therapy Defibrillator (CRTD)
-
Ablation (ABL) catheter
Cardiac Vascular Segment (CVS)
-
Stent graft
-
Transcatheter heart valve
-
Mechanical heart valve
Percutaneous Peripheral Intervention (PPI) and neurovascular
-
Peripheral vascular stent
-
Carotid artery stent
-
Embolic coil
Diabetes Mellitus Segment (DMS), large-sized medical equipment and others
-
Insulin pump
-
Continuous Glucose Monitoring (CGM)
-
Computed Tomography (CT)
WIN PARTNERS GROUP
